Name | PCSK9-IN-22 |
---|
Description | PCSK9-IN-22 (compound 29) is an orally active inhibitor of PCSK9. PCSK9-IN-22 inhibits the interaction of the protein with LDLR in vivo[1]. |
---|---|
Related Catalog | |
References |
[1]. Phillip Albert Coghlan, et al. Heterocyclic inhibitors of pcsk9. WO2022133529A1. 2022-06-30. |
Molecular Formula | C28H30N6O |
---|---|
Molecular Weight | 466.58 |